298 related articles for article (PubMed ID: 15877889)
21. Potential modulation of plasma ghrelin and glucagon-like peptide-1 by anorexigenic cannabinoid compounds, SR141716A (rimonabant) and oleoylethanolamide.
Cani PD; Montoya ML; Neyrinck AM; Delzenne NM; Lambert DM
Br J Nutr; 2004 Nov; 92(5):757-61. PubMed ID: 15533263
[TBL] [Abstract][Full Text] [Related]
22. Regulation of glucagon-like peptide-1-(7-36) amide, peptide YY, and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum.
Dumoulin V; Dakka T; Plaisancie P; Chayvialle JA; Cuber JC
Endocrinology; 1995 Nov; 136(11):5182-8. PubMed ID: 7588257
[TBL] [Abstract][Full Text] [Related]
23. Fermentable dietary fiber increases GLP-1 secretion and improves glucose homeostasis despite increased intestinal glucose transport capacity in healthy dogs.
Massimino SP; McBurney MI; Field CJ; Thomson AB; Keelan M; Hayek MG; Sunvold GD
J Nutr; 1998 Oct; 128(10):1786-93. PubMed ID: 9772150
[TBL] [Abstract][Full Text] [Related]
24. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults.
Parnell JA; Reimer RA
Am J Clin Nutr; 2009 Jun; 89(6):1751-9. PubMed ID: 19386741
[TBL] [Abstract][Full Text] [Related]
25. Effects of age on concentrations of plasma cholecystokinin, glucagon-like peptide 1, and peptide YY and their relation to appetite and pyloric motility.
MacIntosh CG; Andrews JM; Jones KL; Wishart JM; Morris HA; Jansen JB; Morley JE; Horowitz M; Chapman IM
Am J Clin Nutr; 1999 May; 69(5):999-1006. PubMed ID: 10232642
[TBL] [Abstract][Full Text] [Related]
26. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
Svane MS; Jørgensen NB; Bojsen-Møller KN; Dirksen C; Nielsen S; Kristiansen VB; Toräng S; Wewer Albrechtsen NJ; Rehfeld JF; Hartmann B; Madsbad S; Holst JJ
Int J Obes (Lond); 2016 Nov; 40(11):1699-1706. PubMed ID: 27434221
[TBL] [Abstract][Full Text] [Related]
27. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
Baggio LL; Huang Q; Brown TJ; Drucker DJ
Gastroenterology; 2004 Aug; 127(2):546-58. PubMed ID: 15300587
[TBL] [Abstract][Full Text] [Related]
28. Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents.
Zhou J; Martin RJ; Tulley RT; Raggio AM; McCutcheon KL; Shen L; Danna SC; Tripathy S; Hegsted M; Keenan MJ
Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1160-6. PubMed ID: 18796545
[TBL] [Abstract][Full Text] [Related]
29. The impact of oligofructose on stimulation of gut hormones, appetite regulation and adiposity.
Daud NM; Ismail NA; Thomas EL; Fitzpatrick JA; Bell JD; Swann JR; Costabile A; Childs CE; Pedersen C; Goldstone AP; Frost GS
Obesity (Silver Spring); 2014 Jun; 22(6):1430-8. PubMed ID: 24715424
[TBL] [Abstract][Full Text] [Related]
30. Effects of oligofructose on appetite profile, glucagon-like peptide 1 and peptide YY3-36 concentrations and energy intake.
Verhoef SP; Meyer D; Westerterp KR
Br J Nutr; 2011 Dec; 106(11):1757-62. PubMed ID: 21679485
[TBL] [Abstract][Full Text] [Related]
31. Modulation of gut mucosal biofilms.
Kleessen B; Blaut M
Br J Nutr; 2005 Apr; 93 Suppl 1():S35-40. PubMed ID: 15877893
[TBL] [Abstract][Full Text] [Related]
32. Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors.
Holst JJ
Expert Opin Emerg Drugs; 2004 May; 9(1):155-66. PubMed ID: 15155141
[TBL] [Abstract][Full Text] [Related]
33. The effects of dietary fibre type on satiety-related hormones and voluntary food intake in dogs.
Bosch G; Verbrugghe A; Hesta M; Holst JJ; van der Poel AF; Janssens GP; Hendriks WH
Br J Nutr; 2009 Jul; 102(2):318-25. PubMed ID: 19144213
[TBL] [Abstract][Full Text] [Related]
34. [Glucagon-like peptides--synthesis, biological actions and some clinical implications].
Otto Buczkowska E; Dworzecki T
Przegl Lek; 2004; 61(9):947-50. PubMed ID: 15803906
[TBL] [Abstract][Full Text] [Related]
35. Attenuated processing of proglucagon and glucagon-like peptide-1 in carboxypeptidase E-deficient mice.
Friis-Hansen L; Lacourse KA; Samuelson LC; Holst JJ
J Endocrinol; 2001 Jun; 169(3):595-602. PubMed ID: 11375130
[TBL] [Abstract][Full Text] [Related]
36. Effects of resistant starch, a non-digestible fermentable fiber, on reducing body fat.
Keenan MJ; Zhou J; McCutcheon KL; Raggio AM; Bateman HG; Todd E; Jones CK; Tulley RT; Melton S; Martin RJ; Hegsted M
Obesity (Silver Spring); 2006 Sep; 14(9):1523-34. PubMed ID: 17030963
[TBL] [Abstract][Full Text] [Related]
37. Dipeptidyl peptidase IV inhibitor treatment stimulates beta-cell survival and islet neogenesis in streptozotocin-induced diabetic rats.
Pospisilik JA; Martin J; Doty T; Ehses JA; Pamir N; Lynn FC; Piteau S; Demuth HU; McIntosh CH; Pederson RA
Diabetes; 2003 Mar; 52(3):741-50. PubMed ID: 12606516
[TBL] [Abstract][Full Text] [Related]
38. Glucagon-like peptide-1 (GLP-1) increases in plasma and colon tissue prior to estrus and circulating levels change with increasing age in reproductively competent Wistar rats.
Johnson ML; Saffrey MJ; Taylor VJ
Peptides; 2017 Apr; 90():55-62. PubMed ID: 28237410
[TBL] [Abstract][Full Text] [Related]
39. Stimulatory effect of beta-adrenergic agonists on ileal L cell secretion and modulation by alpha-adrenergic activation.
Claustre J; Brechet S; Plaisancie P; Chayvialle JA; Cuber JC
J Endocrinol; 1999 Aug; 162(2):271-8. PubMed ID: 10425466
[TBL] [Abstract][Full Text] [Related]
40. The effect of meal frequency in a reduced-energy regimen on the gastrointestinal and appetite hormones in patients with type 2 diabetes: A randomised crossover study.
Belinova L; Kahleova H; Malinska H; Topolcan O; Windrichova J; Oliyarnyk O; Kazdova L; Hill M; Pelikanova T
PLoS One; 2017; 12(4):e0174820. PubMed ID: 28369078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
